Literature DB >> 17611727

[Emergency therapy for acute heart failure].

H Ebelt1, K Werdan.   

Abstract

Acute heart failure (AHF) is defined as the rapid onset of symptoms and signs secondary to abnormal heart function which may occur with or without previous cardiac disease. Diagnosis and classification of severity are primarily based on clinical findings. The conditions leading to and reasons for acute heart failure which require specific therapeutic interventions should always be taken into consideration. Immediate goals in the guideline-oriented treatment of AHF are to improve the patient's symptoms and stabilize the hemodynamic condition. Medical therapy - besides oxygen supply - consists of the application of vasodilators, diuretics, and inotropes (especially dobutamine) depending both on the patient's clinical state and hemodynamic parameters. In the presence of ongoing signs of hypoxia, non-invasive ventilation has to be considered early. Bradycardia in AHF patients should initially be treated with atropine; a temporal pacemaker has to be inserted if no response is achieved by medical therapy. Ventricular fibrillation and tachycardia require immediate cardioversion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17611727     DOI: 10.1007/s00108-007-1897-7

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  25 in total

1.  Guidelines for the diagnosis and treatment of chronic heart failure.

Authors:  W J Remme; K Swedberg
Journal:  Eur Heart J       Date:  2001-09       Impact factor: 29.983

Review 2.  Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization.

Authors:  Parag Jain; Barry M Massie; Wendy A Gattis; Livin Klein; Mihai Gheorghiade
Journal:  Am Heart J       Date:  2003-02       Impact factor: 4.749

3.  Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology.

Authors:  Markku S Nieminen; Michael Böhm; Martin R Cowie; Helmut Drexler; Gerasimos S Filippatos; Guillaume Jondeau; Yonathan Hasin; José Lopez-Sendon; Alexandre Mebazaa; Marco Metra; Andrew Rhodes; Karl Swedberg; Silvia G Priori; Maria Angeles Alonso Garcia; Jean-Jacques Blanc; Andrzej Budaj; Martin R Cowie; Veronica Dean; Jaap Deckers; Enrique Fernandez Burgos; John Lekakis; Bertil Lindahl; Gianfranco Mazzotta; João Morais; Ali Oto; Otto A Smiseth; Maria Angeles Alonso Garcia; Kenneth Dickstein; Anibal Albuquerque; Pedro Conthe; Maria Crespo-Leiro; Roberto Ferrari; Ferenc Follath; Antonello Gavazzi; Uwe Janssens; Michel Komajda; João Morais; Rui Moreno; Mervyn Singer; Satish Singh; Michal Tendera; Kristian Thygesen
Journal:  Eur Heart J       Date:  2005-01-28       Impact factor: 29.983

Review 4.  What is evidence-based, what is new in medical therapy of acute heart failure?

Authors:  Wolfram Grimm
Journal:  Herz       Date:  2006-11       Impact factor: 1.443

5.  Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study.

Authors:  Yasser Sakr; Konrad Reinhart; Jean-Louis Vincent; Charles L Sprung; Rui Moreno; V Marco Ranieri; Daniel De Backer; Didier Payen
Journal:  Crit Care Med       Date:  2006-03       Impact factor: 7.598

6.  Evidence for existence of intramyocardial steal.

Authors:  J G Reves; W Erdmann; M Mardis; R B Karp; M King; W A Lell
Journal:  Adv Exp Med Biol       Date:  1977 Jul 4-7       Impact factor: 2.622

7.  Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients.

Authors:  T Killip; J T Kimball
Journal:  Am J Cardiol       Date:  1967-10       Impact factor: 2.778

8.  Gender-specific risk stratification with B-type natriuretic peptide levels in patients with acute dyspnea: insights from the B-type natriuretic peptide for acute shortness of breath evaluation study.

Authors:  Michael Christ; Kirsten Laule-Kilian; Willibald Hochholzer; Theresia Klima; Tobias Breidthardt; Andre P Perruchoud; Christian Mueller
Journal:  J Am Coll Cardiol       Date:  2006-10-17       Impact factor: 24.094

Review 9.  [Cardiogenic shock: pathophysiology, clinics, therapeutical options and perspectives].

Authors:  R Prondzinsky; K Werdan; M Buerke
Journal:  Internist (Berl)       Date:  2004-03       Impact factor: 0.743

10.  Potential deleterious effects of inotropic agents in the therapy of chronic heart failure.

Authors:  A M Katz
Journal:  Circulation       Date:  1986-03       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.